Sort
27,075 grants matching “cholesterol”
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2022 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2020 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2021 · HL
Lymphocytes, Cholesterol, and Atherosclerosis
$544,733Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2012 · HL
The HHER Lifestyle Program for CVD Risk Reduction
$544,718University Of South Carolina At Columbia · R01 · FY2004 · HL
Hepatic Wnt/LRP6 Regulation of Plasma Lipids
$544,492Arya Mani · Yale University · R01 · FY2015 · HL
Insulin Receptor Structure and Turnover
$544,377C Ronald Kahn · Joslin Diabetes Center · R37 · FY2013 · DK
Genetic Epidemiology of Change in CVD Risk Factors
$544,327David Michael Hallman · University Of Texas Hlth Sci Ctr Houston · R01 · FY2010 · HL
Evaluation of a Civic Engagement Approach to Catalyze Built Environment Changeand Promote Healthy Eating and Physical Activity Among Rural Residents
$544,324Rebecca Anne Seguin-Fowler · Texas A&M Agrilife Research · R01 · FY2021 · CA
Determining the role of lipid droplets and their therapeutic potential in glioblastoma
$544,245Deliang Guo · Ohio State University · R01 · FY2025 · NS
Ethanol and mGluR2 signaling
$544,223Rong Chen · Wake Forest University Health Sciences · R01 · FY2025 · AA
IMPLEMENTING MULTICOMPONENT INTERVENTIONS TO TREAT BLOOD DONORS WITH FAMILIAL HYPERCHOLESTEROLEMIA
$544,145Amit Khera · Ut Southwestern Medical Center · R33 · FY2023 · HL
Causal associations of circulating biomarkers with cardiovascular disease
$544,000Erik Ingelsson · Stanford University · R01 · FY2017 · HL
Causal associations of circulating biomarkers with cardiovascular disease
$544,000Erik Ingelsson · Stanford University · R01 · FY2019 · HL
Causal associations of circulating biomarkers with cardiovascular disease
$544,000Erik Ingelsson · Stanford University · R01 · FY2018 · HL
Computational Study of Antimicrobial Peptide-lipid Membrane Interactions
$543,905Max L Berkowitz · University Of North Carolina At Chapel Hill · · FY2010 · BIO
Cardioprotection by extra-small HDL particles
$543,880Jay W Heinecke · University Of Cincinnati · P01 · FY2025 · HL
Sterol Regulatory Element Binding Proteins in regulation of lipid metabolism
$543,851Timothy F Osborne · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · HL
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids
$543,747Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2021 · HL
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients
$543,623Nicole Cherie Schmitt · Emory University · U01 · FY2024 · DC
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease
$543,615Yanqiao Zhang · University Of Arizona · R01 · FY2025 · DK
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease
$543,533Xianlin Han · University Of Texas Hlth Science Center · R56 · FY2019 · AG
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
$543,526Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2011 · HL
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2008 · HL